Malaysia Cardiovascular Devices Market Segmented By Type (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Source (Import, Domestic), By Region and Competition, 2020-2030F

Market Overview

Malaysia Cardiovascular Devices Market was valued at USD 4.14 billion in 2024 and is expected to reach USD 5.84 billion by 2030 with a CAGR of 5.90% during the forecast period. The cardiovascular devices market in Malaysia has witnessed significant growth over the past few years, owing to the increasing adoption of sedentary lifestyles and unhealthy diets in the country. Cardiovascular diseases (CVDs) continue to be a major health concern in Malaysia, with a significant number of people affected each year. It has been reported that cardiovascular disease cases increase by 5% every year in Malaysia. Sedentary lifestyles refer to a lack of physical activity, which can be a result of a variety of factors such as long working hours, increased use of technology, and the availability of modern conveniences.

In Malaysia, many people lead sedentary lifestyles due to long commutes, desk-bound jobs, and a lack of access to recreational facilities. This lack of physical activity can lead to a variety of health problems, including obesity (according to the National Health and Morbidity Survey (NHMS) 2019, Malaysia’s obesity rate amongst 18 years and above is reported to be 19.7%), hypertension (approximately 30% of Malaysians aged 18 years and above are affected from hypertension, according to the Malaysian National Health and Morbidity Survey 2019), and diabetes (the diabetes prevalence in Malaysia ranges from 7.3% to 23.8%, according to published reports), which are all risk factors for CVDs.

Key Market Drivers

High Prevalence of Cardiovascular Diseases

Cardiovascular disease (CVD) has consistently accounted for nearly 23.3% of all deaths in Malaysia for many years, according to Health Minister Datuk Seri Dr Dzulkefly Ahmad. High cholesterol is a major risk factor for atherosclerotic CVD, a leading cause of morbidity and mortality. The 2023 National Health and Morbidity Survey revealed that 33.3% of adults in Malaysia, or 7.6 million people aged 18 and above, suffer from high cholesterol. More worryingly, one in two adults with high cholesterol don't even know they have it because increased cholesterol levels often don't have symptoms. Despite treatment, the challenge has always been there; the control of cholesterol levels is still not at target for many patients, especially those with high risk.

Government Initiatives to Enhance Healthcare Infrastructure

The Malaysian government has made significant efforts in recent years to improve the country's healthcare infrastructure and services. One of the key initiatives undertaken is the construction of new hospitals and healthcare facilities, especially in areas where there is a shortage of healthcare services. This has helped to improve access to healthcare for people living in rural and remote areas. Additionally, the government has invested in medical technology and equipment to improve the quality of healthcare services. This includes the purchase of advanced medical equipment and the establishment of centers of excellence in various medical specialties, such as cardiology, to ensure that patients receive the highest quality of care.

Download Free Sample Report

Key Market Challenges

High Costs Associated with Advanced Cardiovascular Devices

Devices like pacemakers, defibrillators, and transcatheter valves can be costly, impacting accessibility, especially in low-income regions. In Malaysia, high device costs may limit adoption, particularly in budget-constrained healthcare settings. The financial burden associated with these advanced devices poses a significant barrier to their widespread implementation, potentially leading to disparities in the quality of cardiovascular care across different socioeconomic groups.

Stringent Regulatory and Approval Processes

Cardiovascular devices are subject to rigorous regulatory scrutiny to ensure safety and efficacy, which can delay product approvals. In Malaysia, regulatory hurdles may restrict the availability of new devices, impacting market growth. The complex and time-consuming approval processes can deter manufacturers from introducing innovative products to the Malaysian market, thereby limiting the options available to healthcare providers and patients.

Key Market Trends

Growth in Wearable and Home-Based Monitoring Devices

Wearable ECGs, smartwatches with heart rate monitoring, and remote monitoring devices allow patients to track their heart health at home. In Malaysia, demand for wearable monitoring devices is increasing as patients seek convenient, accessible healthcare solutions. These devices empower patients to take a proactive role in managing their heart health, leading to early detection of potential issues and timely medical intervention. The integration of such technologies into patient care aligns with the global shift towards personalized and preventive healthcare.

Advancements in Artificial Intelligence (AI) for Cardiac Imaging and Diagnosis

AI-powered imaging solutions improve diagnostic accuracy and help cardiologists identify early signs of heart disease. In Malaysia, demand for AI-enabled devices is rising as healthcare providers leverage technology to enhance diagnosis and treatment planning. These advancements facilitate more precise and efficient analysis of cardiac images, leading to better patient outcomes. The adoption of AI in cardiology also supports the optimization of healthcare resources by streamlining workflows and reducing the burden on medical professionals. ​

Segmental Insights

Type Insights

Based on Type, Diagnostic and monitoring devices dominate the market due to their widespread use in both hospital and outpatient settings for early detection and management of cardiovascular conditions. These include ECG machines, Holter monitors, blood pressure monitors, and wearable cardiac monitors. Their dominance stems from the increasing incidence of heart diseases like hypertension, arrhythmias, and ischemic heart disease in Malaysia, which require ongoing monitoring. Government initiatives focused on preventive healthcare and early intervention, such as the National Strategic Plan for Non-Communicable Diseases (NSP-NCD), have emphasized the need for routine cardiovascular screening. This has led to more public health campaigns, subsidized check-ups, and integration of cardiovascular diagnostics into primary care services, further strengthening demand for such devices.

Download Free Sample Report

Regional Insights

Based on the region, ​ West Malaysia holds the largest share, largely due to its more developed healthcare infrastructure and higher concentration of medical facilities. Major urban centers such as Kuala Lumpur, Selangor, Penang, and Johor host some of the country’s most advanced hospitals and specialized cardiac centers. These facilities are typically better equipped with the latest cardiovascular technologies, making them central to the diagnosis and treatment of heart-related conditions. The higher population density in West Malaysia also means a greater number of patients requiring cardiovascular care, which further drives demand for these devices.

Additionally, West Malaysia benefits from stronger economic development, enabling both public and private healthcare providers to invest in advanced medical equipment, including pacemakers, stents, and heart monitoring systems. The presence of medical tourism hubs in this region, attracting patients from neighboring countries, adds to the growing use of cardiovascular devices. Government healthcare initiatives and public investments are also more heavily concentrated in West Malaysia, which boosts the availability and use of specialized cardiac equipment in public hospitals. While East Malaysia is gradually expanding its healthcare services, the infrastructure and patient volumes in West Malaysia position it as the dominant region in the country’s cardiovascular devices market.

Recent Developments

• In July 2023, Dexcom received authorization for the G7 continuous glucose monitoring (CGM) system in Canada. This system is now available for individuals aged two and older, regardless of the type of diabetes they have.
• In March 2023, Dexcom announced that residents of Manitoba living with either type 1 or type 2 diabetes are eligible for coverage of its G6 CGM system. At the time of the announcement, Manitoba stood out as the only Canadian province that did not require a preapproval application for coverage, simplifying access to the technology for those in need.

Key Market Players

• B. Braun Medical Supplies Sdn Bhd
• Abbott Medical Malaysia Sdn Bhd
• LivaNova Malaysia SDN BHD
• Edwards Lifesciences (M) Sdn Bhd
• GE Healthcare
• BIOTRONIK Medical Devices (Malaysia) SDN BHD
• Terumo Malaysia Sdn. Bhd.
• FUJIFILM Malaysia Sdn. Bhd.
• Philips Malaysia Sdn Bhd

Report Scope:

In this report, Malaysia cardiovascular devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Malaysia Cardiovascular Devices Market, By Type:

o   Diagnostic & Monitoring Devices

o   Surgical Devices

·         Malaysia Cardiovascular Devices Market, By Application:

o   Coronary Artery Disease

o   Cardiac Arrhythmia

o   Heart Failure

o   Others

·         Malaysia Cardiovascular Devices Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Others

·         Malaysia Cardiovascular Devices Market, By Source:

o   Import

o   Domestic

·         Malaysia Cardiovascular Devices Market, By Region:

o   West Malaysia

o   East Malaysia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Malaysia cardiovascular devices market.

Available Customizations:

Malaysia Cardiovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Malaysia cardiovascular devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com